Showing results (271-280 of 2,242) with videos related to

Sort By:
Pageof 225
Talanta|February 1, 1980
Pre-concentration of trace metals from sea-water for determination by graphite-furnace atomic-absorption spectrometryR E Sturgeon, S S Berman, A Desaulniers, et al.
Immunology|May 1, 1987
C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognitionL L Baum, B Johnson, S Berman, et al.
Annals of Plastic Surgery|April 23, 1999
Internal fixation of phalangeal fractures using titanium miniplatesK S Berman, D M Rothkopf, J V Shufflebarger, et al.
Archives of Internal Medicine|October 24, 2002
Ticlopidine-induced lupus: a report of 4 casesRobert F Spiera, Rosanne S Berman, Andrew J Werner, et al.
Neuroimmunomodulation|March 1, 1996
Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipopolysaccharideA S Berman, C Chancellor-Freeland, G Zhu, et al.
The American Journal of Cardiology|July 1, 1995
Prior restraint: a Bayesian perspective on the optimization of technology utilization for diagnosis of coronary artery diseaseG A Diamond, T A Denton, D S Berman, et al.
Journal of Clinical Monitoring and Computing|June 17, 2006
Ventilator Y-piece pressure compared with intratracheal airway pressure in healthy intubated childrenOmer Nasiroglu, Bruce Craig Weldon, Lawrence S Berman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 1, 1996
Fast technetium 99m-labeled sestamibi gated single-photon emission computed tomography for evaluation of myocardial functionM Mazzanti, G Germano, H Kiat, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|March 1, 1996
Statistical, epidemiological and fiscal issues in the evaluation of patients with coronary artery diseaseR Hachamovitch, D S Berman, A P Morise, et al.
The Journal of Antibiotics|December 1, 1985
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological propertiesM A Goetz, M Lopez, R L Monaghan, et al.
Pageof 225